SuperworthArq EV/EBIT ARQ
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2021.
- Today, Oct 23, 2026
- n/m
- an operating loss
- Last meaningful
- 233×
- Oct 2025
- 5-year median
- 126×
- 5-year range
- 4.8× to 412×
- Peer median
- 12.7×
Arq has no meaningful EV/EBIT today: it made an operating loss of $53.1M over the last twelve months.
It was last meaningful in Oct 2025, at 233×.
On the days it had one over the last 5 years, its median was 126×, from 4.8× in Jul 2022 to 412× in Nov 2024.
EV/EBIT over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2025 | 233× | 110× | 383× |
| 2024 | 370× | 344× | 412× |
| 2023 | n/m a value too high to mean anything | ||
| 2022 | 11.4× | 4.8× | 15.1× |
| 2021 | 10.4× | 9.8× | 15.1× |
Against its peers
Companies in Chemicals nearest Arq's size, closest first, today.
| Company | EV/EBIT |
|---|---|
| ARQArq | n/m |
| FTLFFitlife Brands | n/m |
| BTMDbiote | 10.5× |
| NAGENiagen Bioscience | 14.9× |
| Peer median | 12.7× |
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on Arq
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.